Kinarus Therapeutics Holding Valuation
Is KNRS undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score 0/6
Price-To-Book vs Peers
Price-To-Book vs Industry
Price-To-Book vs Fair Ratio
Below Fair Value
Significantly Below Fair Value
Key Valuation Metric
Which metric is best to use when looking at relative valuation for KNRS?
Other financial metrics that can be useful for relative valuation.
|What is KNRS's n/a Ratio?|
Price to Book Ratio vs Peers
How does KNRS's PB Ratio compare to its peers?
|KNRS PB Ratio vs Peers|
|Company||PB||Estimated Growth||Market Cap|
HELI Jaya Trishindo
VOL Volatus Aerospace
BVZN BVZ Holding
KNRS Kinarus Therapeutics Holding
Price-To-Book vs Peers: Insufficient data to calculate KNRS's Price-To-Book Ratio vs. peers for valuation analysis.
Price to Earnings Ratio vs Industry
How does KNRS's PE Ratio compare vs other companies in the European Airlines Industry?
Price-To-Book vs Industry: Insufficient data to calculate KNRS's Price-To-Book Ratio vs. industry for valuation analysis.
Price to Book Ratio vs Fair Ratio
What is KNRS's PB Ratio compared to its Fair PB Ratio? This is the expected PB Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
|Current PB Ratio||n/a|
|Fair PB Ratio||n/a|
Price-To-Book vs Fair Ratio: Insufficient data to calculate KNRS's Price-To-Book Fair Ratio for valuation analysis.
Share Price vs Fair Value
What is the Fair Price of KNRS when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: Insufficient data to calculate KNRS's fair value for valuation analysis.
Significantly Below Fair Value: Insufficient data to calculate KNRS's fair value for valuation analysis.
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
Analyst Forecast: Insufficient data to show price forecast.
Discover undervalued companies
- Take a look at our analysis of KNRS's management and see if the CEO's compensation is within a reasonable range, who is on the board and if insiders have been trading lately.
- When valuing a company like this, investors focus more on how they perceive the size of the opportunity, the company's ability to deliver and scale, and the strength of the team. While we are not analysing this type of data at the moment, if you don't know where to start, we recommend reading through Kinarus Therapeutics Holding regulatory filings.